Position in NVS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$11,210,628
+$463,111 QoQ
Shares Held
73,392
-5.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. NVS ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
This page
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,210,628 | 73,392 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $10,747,517 | 77,954 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $10,499,137 | 81,871 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,913,233 | 73,657 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $8,512,389 | 76,358 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $9,935,253 | 102,099 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,546,841 | 109,084 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,172,849 | 114,342 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,725,610 | 121,220 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $12,631,851 | 125,105 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $12,887,734 | 126,524 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,970,567 | 128,536 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $12,240,692 | 133,051 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $12,769,293 | 140,755 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $10,611,604 | 139,608 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $11,599,291 | 137,221 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $11,251,656 | 128,224 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $11,337,424 | 129,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,578,324 | 129,351 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,859,466 | 129,981 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $13,877,421 | 162,347 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $18,408,373 | 194,942 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $17,407,826 | 200,182 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $18,069,510 | 206,887 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $20,001,627 | 242,591 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||